A Pivotal Senate Race in North Carolina
The Daily20 Okt 2020

A Pivotal Senate Race in North Carolina

In the struggle to control the U.S. Senate, one race in North Carolina — where the Republican incumbent, Thom Tillis, is trying to hold off his Democratic challenger, Cal Cunningham — could be crucial.

North Carolina is a classic purple state with a split political mind: progressive in some quarters, while firmly steeped in Southern conservative tradition in others.

Two bombshells have recently upended the race: Mr. Tillis fell ill with the coronavirus after attending an event for Judge Amy Coney Barrett’s Supreme Court nomination without a mask. And Mr. Cunningham’s image was sullied by the emergence of text messages showing that he had engaged in an extramarital affair.

Jonathan Martin, a national political correspondent for The Times, talks us through the race and examines the factors that could determine who prevails.

Guest: Jonathan Martin, a national political correspondent for The New York Times.

For more information on today’s episode, visit nytimes.com/thedaily

Background reading:

  • North Carolina is a linchpin in the 2020 election — the presidency and the Senate could hinge on results in the state.
  • Here’s how the critical senate race was engulfed in chaos in a single night.

Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Episoder(2771)

The Republican Attempt to Impeach President Biden

The Republican Attempt to Impeach President Biden

Speaker Kevin McCarthy has ordered an impeachment inquiry into President Biden, putting into motion the third formal attempt by Congress to remove a president in the past four years.Luke Broadwater,  ...

15 Sep 202328min

An Armored Train and a Dangerous New Alliance

An Armored Train and a Dangerous New Alliance

In a rare move, the leader of North Korea, Kim Jong-un, traveled outside his country this week to meet with the Russian president, Vladimir V. Putin. Julian Barnes, a national security reporter for Th...

14 Sep 202327min

A New Covid Shot for a New Covid Era

A New Covid Shot for a New Covid Era

On Tuesday afternoon, the U.S. government recommended that almost every American begin taking a new annual vaccine for Covid, a milestone in the nation’s three-year battle against the virus.Apoorva Ma...

13 Sep 202326min

A Breaking Point for the U.S. Auto Industry

A Breaking Point for the U.S. Auto Industry

Later this week, as many as 150,000 U.S. autoworkers may walk out in a historic strike against the three Detroit automakers, General Motors, Ford and Stellantis. The United Auto Workers union and the ...

12 Sep 202330min

U.S. v. Google

U.S. v. Google

For years, the government has been trying to rein in Big Tech, pursuing some of the largest and most powerful companies on the internet. This week, the government takes on Google in the first monopoly...

11 Sep 202324min

The Sunday Read: ‘Wikipedia’s Moment of Truth’

The Sunday Read: ‘Wikipedia’s Moment of Truth’

In early 2021, a Wikipedia editor peered into the future and saw what looked like a funnel cloud on the horizon: the rise of GPT-3, a precursor to the new chatbots from OpenAI. When this editor — a pr...

10 Sep 202351min

A Tragic Fire and Broken Promises in South Africa

A Tragic Fire and Broken Promises in South Africa

This episode contains descriptions of severe injuries. Last week, a devastating fire swept through a derelict building in Johannesburg that housed desperate families who had no place else to go. The a...

8 Sep 202331min

Why One Drug Company Held Back a Better Drug

Why One Drug Company Held Back a Better Drug

For decades, drugmakers have argued that patents are critical to bringing new drugs to the market. But in 2004, when a promising H.I.V. treatment emerged, Gilead Sciences decided to slow-walk its rele...

7 Sep 202335min

Populært innen Politikk og nyheter

giver-og-gjengen-vg
aftenpodden
aftenpodden-usa
forklart
stopp-verden
i-retten
lydartikler-fra-aftenposten
popradet
nokon-ma-ga
det-store-bildet
dine-penger-pengeradet
rss-ness
aftenbla-bla
hanna-de-heldige
rss-gukild-johaug
e24-podden
fotballpodden-2
frokostshowet-pa-p5
rss-dannet-uten-piano
grasoner-den-nye-kalde-krigen